Phosphoinositide hydrolysis in platelets stimulated by thrombin is thought to be regulated by a pertussis toxin-sensitive guanine nucleotide binding protein (G protein) referred to as Gp. The present studies examine the role of GP in platelet responses to the thromboxane A2 analogue U46619 and in the pathway by which the phosphoinositide hydrolysis product inositol 1,4,5-triphosphate (IP3) causes secretion. In permeabilized platelets, U46619 caused phosphatidic acid formation and secretion, which were abolished by the G protein inhibitor, guanosine 5'-O(2-thiophosphate) (GDP,6S). Unlike thrombin, however, U46619-induced phosphoinositide hydrolysis was unaffected by pertussis toxin, and U46619 was unable to inhibit the I32PIADP ribosylation of the 42-kD pertussis toxin substrate in platelets. IP3-induced secretion, which is known to depend upon intracellular Ca release and subsequent arachidonic acid metabolism, was also inhibited by GDPj#S, as was Ca-induced secretion. These observations suggest (a) that platelet thromboxane A2 (TxA2) receptors are coupled to a toxin-resistant form of Gp distinct from the one that is coupled to thrombin receptors, and (b) that TxA2-stimulated phosphoinositide hydrolysis may serve as a feedback mechanism by which stimuli for arachidonic acid release, such as IP3 and Ca, amplify responses to agonists.
Introduction
The hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2)' by phospholipase C is one of the earliest events known to occur when platelets are activated by agonists such as thrombin (1) (2) (3) (4) . This process produced two key mediators of further platelet activation: diacylglycerol and inositol 1,4,5-triphosphate (IP3). Diacylglycerol has been shown to cause protein phosphorylation 1 . Abbreviations used in this paper: G protein, guanine nucleotide binding protein; GDP#S, guanosine 5'-O-2-thiophosphate); Gi, guanine nucleotide binding protein that mediates inhibition of adenylate cyclase; Gp, guanine nucleotide binding protein that regulates phospholipase C activation: Gpp(NH)p, guanyl-5'-yl imidodiphosphate; IP3, inositol 1,4,5-triphosphate; PIP2, phosphatidylinositol 4,5-bisphosphate; TxA2, thromboxane A2. and secretion and the exposure of fibrinogen receptors on the platelet surface, events thought to be mediated by protein kinase C (5) (6) (7) . In platelets that have been permeabilized with saponin, exogenous IP3 causes secretion, protein phosphorylation, fibrinogen receptor exposure, and aggregation (7) (8) (9) (10) (11) (12) . In this case, however, these events appear to be a consequence of the ability ofIP3 to trigger the release ofCa sequestered within the plateletdense tubular system (7, 10, (13) (14) (15) . The evidence that supports this conclusion is as follows. First, in platelets permeabilized with saponin, physiologically relevant concentrations ofIP3 cause both Ca release from the platelet dense tubular system and dense granule secretion. The dose-response curves for these two processes are essentially identical. Secondly, the addition of EGTA to the permeabilized platelets has no effect on IP3-induced Ca release, but completely inhibits IP3-induced secretion. Thirdly, in platelets permeabilized by voltage discharge, increases in the cytosolic free Ca concentration caused by manipulation of the extracellular Ca concentration also cause secretion (16) (17) (18) .
One mechanism by which the Ca discharged by IP3 might stimulate secretion is by stimulating arachidonic acid release from phospholipids such as phosphatidylcholine. It has recently been shown using platelets permeabilized with saponin that IP3-induced secretion, protein phosphorylation, and platelet aggregation are inhibited by aspirin, suggesting that these processes are partially dependent upon the products of arachidonic acid metabolism such as thromboxane A2 (TxA2) (10) (11) (12) 19 (16) (17) (18) 26) , and that inhibitors of G protein function, such as guanosine 5'-O42-thiophosphate) (GDP,3S) (27, 28) and pertussis toxin, will inhibit platelet responses to thrombin (26) . In a previous study from this laboratory (26) , inhibition ofthrombin by pertussis toxin was associated with the ADP ribosylation of a protein with an apparent molecular mass of 42 kD that comigrates with the a subunit of Gi, the G protein that mediates inhibition of adenylate cyclase. The extent of inhibition by per-tussis toxin ofthrombin-stimulated phosphoinositide hydrolysis paralleled the inhibition of thrombin's ability to suppress prostacyclin (PGI2)-stimulated cyclic AMP (cAMP) formation and correlated with the extent of labeling of the 42-kD protein.
With this background, the present studies were designed to address two aspects of the regulation of platelet activation: (a) to determine whether TxA2-stimulated phosphoinositide hydrolysis in platelets is, like thrombin-stimulated phosphoinositide hydrolysis, mediated by a G protein and, if so, to examine the properties of that G protein, and (b) to determine whether IP3-stimulated arachidonic acid metabolism is able to amplify platelet responses to agonists by "feedback" activation of phosphoinositide hydrolysis.
Methods
Platelet preparation. Washed platelets were prepared from fresh human blood as previously described (8) . In brief, the platelets were sedimented from platelet-rich plasma, washed once in buffer containing 140 mM NaCl, 20 mM Hepes, and I mM EDTA, pH 7.1, and then resuspended in buffer containing 137 mM NaCl, 2.7 mM KC1, 1 mM MgCl2, 3.3 mM NaH2PO4, and 20 mM Hepes, pH 7.4. The final cell count was adjusted to 1.4 X 109/ml. For the studies of secretion, the platelets were loaded with ['4C]serotonin (New England Nuclear, Boston, MA) by addition ofthe labeled compound to platelet-rich plasma (8) . When noted, the platelet-rich plasma was also incubated with 1 mM aspirin for 30 min to inhibit cyclooxygenase. In some experiments, successful inhibition of eicosanoid synthesis was confirmed by measuring arachidonic acidinduced platelet aggregation (8) .
Serotonin releasefrom saponin-treatedplatelets. The (21) (22) (23) 30) and GTPase activity (31) in platelets. In order to determine whether these responses reflect the coupling of one or more G proteins to platelet TxA2 receptors, we first examined the effects of the G protein inhibitor GDPBS on phosphoinositide hydrolysis and secretion in permeabilized platelets stimulated with the TxA2 analogue, U46619. In the studies shown in Fig. 1 , saponin-treated platelets were stimulated with 10 uM U46619 in the presence of various concentrations of GDP(#S. Phosphoinositide hydrolysis was detected by measuring phosphatidic acid formation. In the absence ofGDP(BS, U46619 caused a 2.5-fold increase in phosphatidic acid formation. GDP(BS inhibited this increase in a concentration-dependent manner. Half-maximal inhibition required -40MuM GDPBS, which is similar to the GDP,3S concentration required to inhibit thrombin-induced diacylglycerol formation and PGI2-stimulated cAMP formation in saponintreated platelets (26) . GDPBS also inhibited U46619-induced secretion (Fig. 2) . At 1 MM U46619, inhibition of secretion was also half-maximal at -40 MM GDPBS (not shown).
Pertussis toxin has no apparent effect on intact platelets. However, we have recently demonstrated that the addition of the toxin to platelets permeabilized with saponin results in the inhibition of thrombin-stimulated phosphoinositide hydrolysis and of thrombin's ability to suppress PGI2-stimulated cAMP formation (26) . This suggests that both Gp and Gi are affected by the toxin. In order better to characterize the G proteins coupled to platelet TxA2 receptors, we measured U46619-induced phosphatidic acid formation in saponin-treated platelets preincubated with pertussis toxin. Under conditions in which thrombin-induced phosphatidic acid formation was inhibited by 250 -60%, the toxin had no effect on U46619-induced phosphatidic acid formation (Fig. 3, top) . We also compared the ability of U46619 and thrombin to cause Gi-dependent inhibition ofPGIr stimulated cAMP formation. Intact platelets were preincubated with thrombin or U46619 before adding 1 uiM PGI2. The formation of cAMP was followed for the next 2 min. Thrombin suppressed cAMP formation by > 80%. Under the same conditions, U466 19 had no effect (Fig. 3, bottom) .
These centration ofU466 19 which maximally stimulates phosphoinositide hydrolysis and secretion had no effect (Fig. 4) . In agreement with the functional studies, this suggests that TxA2 receptors are not coupled to either toxin-sensitive G protein.
Role ofTxArstimulated phosphoinositide hydrolysis in IPr induced secretion. Several investigators have demonstrated that IP3-induced secretion in permeabilized platelets is blocked by inhibitors of cyclooxygenase such as aspirin or indomethacin (10-12), observations that we have confirmed (19). Aspirin has no effect on Ca release from the platelet-dense tubular system in response to IP3 (8) . Therefore, in order to assess the contribution of G protein-dependent phosphoinositide hydrolysis in IP3-induced secretion, we examined the effect ofGDPj3S on IP3-induced secretion and the effect of GDP(BS and aspirin on Cainduced secretion. In the studies shown in Fig. 5 , IP3-induced secretion was measured at various GDPBS concentrations. GDP(3S completely inhibited IP3-induced secretion. Inhibition was half-maximal at approximately the same GDPj3S concentration as that which inhibited U46619-induced phosphatidic acid formation and secretion. GDP#S also inhibited Ca-induced secretion. The inhibition was not complete, but closely resembled the inhibition ofCa-induced secretion seen with aspirin (Fig. 6) .
In contrast to these results, we have previously shown that GDPBS has no effect on secretion caused by the diacylglycerol analogue l-oleoyl-2-acetyl-glycerol (OAG) or on Ca release in response to IP3 (26) . Taken together, these observations suggest that effects of GDPjBS are on phosphoinositide hydrolysis and not on the secretory mechanism initiated by newly-formed diacylglycerol. If, as is suggested by these data, agonist-mediated phosphoinositide hydrolysis can cause secretion either directly via diacylglycerol or indirectly via IP3/Ca-stimulated arachidonic acid metabolism, then the effects of aspirin on agonist-induced secretion might be expected to vary with the strength ofthe initial stimulus for phosphoinositide hydrolysis. This is known to be the case for thrombin. However, in the case of thrombin, there is also evidence that secretion can occur in the absence of phosphoinositide hydrolysis (26) . Therefore, in order to have as specific a stimulus for G protein-mediated phosphoinositide hydrolysis as possible, we examined the effects of aspirin on secretion caused by the nonhydrolyzable GTP analogue, Gpp(NH)p. As is shown in Fig. 7 , at low Gpp(NH)p concentrations serotonin release was markedly inhibited by aspirin. At higher Gpp(NH)p concentrations, however, maximal secretion occurred despite the aspirin.
Discussion
There is now good evidence in platelets that phospholipase C is coupled to thrombin receptors by a G protein. Studies from this laboratory suggest that the a subunit of this G protein has a molecular mass of -42 kD and is a substrate for pertussis toxin (26) . Based upon similar types of evidence, it appears that a G protein, commonly referred to as Gp, is also responsible for phospholipase C activation in an ever-growing list of tissues, including insect salivary glands, mast cells, neutrophils, adipocytes, and hepatocytes (31) (32) (33) (34) (35) . To date, Gp has been characterized functionally, but has not been isolated. Adding to the uncertainties about the properties of Gp is the observation that in some tissues, including platelets, neutrophils, HL-60 cells, and mast cells, agonist or hormone-induced phosphoinositide hydrolysis is inhibited by pertussis toxin, whereas in other tissues it is not. This difference does not appear to be due to differences in the ability of the pertussis toxin to enter cells. In several of the cases in which it was not possible to demonstrate inhibition of phosphoinositide hydrolysis, it was possible to demonstrate other effects of the toxin, such as ADP ribosylation of GQ.
It has recently been shown that platelets have specific, highaffinity receptors for TxA2/PGH2 analogues (20) . Although the precise location of these receptors has yet to be determined, the available data suggest that they are located on the platelet surface. Two pieces of evidence suggest that these receptors are also coupled to phospholipase C by a G protein. (36) suggested that platelet endoperoxides can in fact inhibit cAMP formation. However, those studies, in contrast to the present studies and those of Best et al. (37) , were performed using stirred platelets in plasma at 370C, conditions in which platelet aggregates were formed. Under these circumstances, released ADP, not TxA2, may have mediated the suppression of adenylate cyclase. (26) . Based upon studies performed with the well-characterized adenylate cyclase regulatory system, this appears to be due to the ability ofthrombin to dissociate the heterotrimeric G proteins coupled to thrombin receptors into (3/y dimers and free a subunits which are no longer substrates for the toxin (38) . We found that U466 19 had no effect on PGI2-stimulated cAMP formation and caused toxin-insensitive phosphoinositide hydrolysis and, in contrast to thrombin, U466 19 had no effect on the [32P]ADP ribosylation of the 42-kD protein.
It is not immediately obvious why within a single tissue the G protein responsible for the same set of responses to different agonists should be affected by pertussis toxin in some cases, but not in others-yet this appears to be the case in platelets. It may also be the case in hepatocytes where Johnson and co-workers (39) have recently reported that pertussis toxin inhibits phospholipase C activation by epidermal growth factor but not by angiotensin II. It is also not clear why the function associated with Gp should be sensitive to pertussis toxin in some tissues, but not others. Gp has yet to be isolated from any tissue in which there is functional evidence for its existence. The sole identifiable pertussis toxin substrate in platelets co-migrates on SDS gels with the a subunit of Gi. Two recent studies have shown that hormone-stimulated phosphoinositide hydrolysis can be restored in pertussis toxin-treated membranes with HL-60 cells and neutrophils by adding back purified Gi (40, 41) . In one of the studies, phosphoinositide hydrolysis was also restored by Go, a wellcharacterized G protein from brain whose function has yet to be determined. One possible explanation for these observations is that the role and the toxin-sensitivity ofG proteins may depend in part upon the characteristics of the receptor to which the G protein is coupled. This remains to be determined.
Feedback amplification ofphosphoinositide hydrolysis. The second issue that was addressed in the present studies is the mechanism by which IP3 causes secretion in platelets. The data obtained are consistent with a model in which IP3 causes secretion by an "indirect" pathway in which the Ca released from the dense tubular system activates phospholipase A2, initiating the arachidonic acid pathway which, in turn, stimulates receptorlinked, guanine nucleotide-regulated phosphoinositide hydrolysis leading to diacylglycerol formation and, finally, granule secretion. Specifically, our data, in combination with those of previous investigators show: (a) that IP3-induced serotonin release, but not IP3-induced Ca release, is inhibited by aspirin, TxA2 antagonists, and GDP(3S and (b) that Ca-induced secretion is also inhibited by aspirin and GDP#S. The effect of GDPBS in this case appears to be confined to inhibition of phosphoinositide hydrolysis because GDP#S was found to inhibit neither IP3-induced Ca release nor secretion in response to the synthetic diacylglycerol, OAG. These observations are incorporated into the model shown in Fig. 8 . In this model positive feedback from the phosphoinositide hydrolysis pathway through the arachidonic acid pathway causes further phosphoinositide hydrolysis by stimulating platelet thromboxane receptors. In order to distinguish the toxin-insensitive G protein coupled to TxA2 receptors from the toxin-sensitive G protein coupled to thrombin receptors, the former is identified as Gp and the latter as G' in Fig. 8 .
In a platelet maximally stimulated with high concentrations of an agonist such as thrombin, such feedback is probably superfluous. However, with low concentrations of thrombin or with agonists that are weaker stimuli for phosphoinositide hydrolysis or with agonists, such as epinephrine, which do not appear to have a primary effect on phosphoinositide hydrolysis (42, 43) , this pathway may serve to reinforce platelet activation. In fact, in epinephrine-stimulated platelets phosphoinositide hydrolysis appears to be entirely attributable to the activation of phospholipase A2 and thromboxane formation (43) . In addition, because TxA2 is released from activated platelets, this process, along with ADP released from platelet-dense granules, would provide a mechanism for the recruitment of additional platelets into a growing platelet plug.
